Jane Street Group LLC Has $987,000 Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Jane Street Group LLC decreased its holdings in Phibro Animal Health Co. (NASDAQ:PAHC) by 13.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 43,847 shares of the company’s stock after selling 7,072 shares during the period. Jane Street Group LLC owned about 0.11% of Phibro Animal Health worth $987,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. nVerses Capital LLC acquired a new position in Phibro Animal Health in the 3rd quarter valued at approximately $70,000. Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health in the third quarter worth $70,000. China Universal Asset Management Co. Ltd. increased its stake in shares of Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after acquiring an additional 1,522 shares during the last quarter. CWM LLC raised its holdings in shares of Phibro Animal Health by 190.8% during the third quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after acquiring an additional 4,175 shares in the last quarter. Finally, Algert Global LLC acquired a new stake in Phibro Animal Health during the second quarter valued at $193,000. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Up 0.1 %

Shares of PAHC stock opened at $21.00 on Wednesday. The stock’s 50 day simple moving average is $23.17 and its 200 day simple moving average is $20.94. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The company has a market capitalization of $850.56 million, a price-to-earnings ratio of 48.84, a PEG ratio of 0.58 and a beta of 0.51.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is 111.63%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on PAHC shares. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 27th. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. Finally, Barclays increased their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.